Brief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
09/06/2026 02:22
BRIEF-Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness June 9 (Reuters) - Noxopharm Ltd NOX.AX:
SOF-SKN MANUFACTURING BEGINS TO ENSURE CLINICAL TRIAL READINESS
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer